Connect Biopharma Holdings Limited (CNTB) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Connect Biopharma Holdings Limited (CNTB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $138.5M, listed on NASDAQ, employing roughly 62 people, carrying a beta of -0.20 to the broader market. Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. Led by Barry D. Quart, public since 2021-03-19.

Snapshot as of May 15, 2026.

Spot Price
$2.39
Net Gamma
$3.6K
Net Delta
-$98.6K
Net Vega
-$1.5K
ATM IV
108.5%
Gamma Concentration
0.67

As of May 15, 2026, Connect Biopharma Holdings Limited (CNTB) aggregate Greeks are net delta -$98.6K, net gamma $3.6K, net vega -$1.5K, ATM IV 108.5%. Gamma concentration is 0.67: dealer gamma is tightly clustered at a few strikes, which tends to pin price. Delta measures directional exposure, gamma measures the rate of delta change, and vega measures sensitivity to implied volatility. Net aggregate Greeks summarize the total dealer book across all strikes and expirations.

How CNTB options greeks Data Feeds Strategy Selection

Strategy selection on Connect Biopharma Holdings Limited options does not derive from any single metric in isolation. The options greeks view above sits inside a broader read: ATM IV currently sits at 108.5% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options greeks data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how options Greeks is reported and how to read the data →

Frequently asked CNTB options greeks questions

What are the CNTB aggregate Greek exposures?
As of May 15, 2026, Connect Biopharma Holdings Limited (CNTB) snapshot Greeks are net delta -$98.6K, net gamma $3.6K, net vega -$1.5K. These aggregate the dealer book across all listed strikes and expirations under the standard customer-versus-dealer sign convention.
What does the CNTB net dealer delta tell us?
Net dealer delta of -$98.6K represents the directional exposure dealers carry from their option inventory. Dealers continuously hedge this exposure with stock, futures, or correlated instruments, so the size of net delta is also the size of hedge flow that will execute as spot moves.
How do CNTB Greeks inform hedging?
Delta tracks first-order directional exposure; gamma tracks how quickly delta changes; vega tracks IV sensitivity. Aggregated dealer Greeks let traders read the dealer-positioning regime: long-gamma regimes mean-revert moves; short-gamma regimes amplify them. Vega exposure indicates how dealer P&L responds to vol shocks and hence the direction of vol-shock hedging flows.